Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.845 USD | +5.13% | -7.04% | -87.43% |
05-09 | Transcript : Amylyx Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
05-09 | Amylyx Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-87.43% | 119M | |
-2.35% | 89.08B | |
+2.76% | 40.9B | |
-13.46% | 32.25B | |
+54.69% | 25.14B | |
-16.02% | 15.39B | |
-9.08% | 11.91B | |
-42.60% | 11.89B | |
-12.82% | 11.64B | |
+7.34% | 9.03B |
- Stock Market
- Equities
- AMLX Stock
- News Amylyx Pharmaceuticals, Inc.
- Mizuho Downgrades Amylyx Pharmaceuticals to Neutral From Buy After Negative Results From Phase 3 PHEONIX Study, Adjusts PT to $4 From $32